While mRNA vaccines can induce strong T-cell responses [19, 20], evidence suggests that the frequency of spike-specific CD4+ T cells following COVID-19 vaccination may be lower in older adults [11, 13, 21]. The gene discussed is CD4; the disease is COVID-19.